Word

REQELJA

Status

Pending

Status Code

731

Status Date

Monday, January 29, 2024

Serial Number

97255833

Mark Type

4000

Filing Date

Monday, February 7, 2022

Published for Opposition

Tuesday, December 27, 2022

Trademark Owner History

Epygenix Therapeutics, Inc. - Owner At Publication

Classifications

5 Pharmaceutical and medical preparations and substances for the treatment of epilepsy and epilepsy disorders, epileptic encephalopathies, convulsions, seizures, diseases of the central nervous system, and neurodegenerative diseases; pharmaceutical and medical preparations and substances for the treatment of pediatric epilepsy and epilepsy disorders, epileptic encephalopathies, convulsions, seizures, diseases of the central nervous system, neurodegenerative diseases; medicinal infusions for the treatment of epilepsy, epilepsy disorders, epileptic encephalopathies, convulsions, seizures, diseases of the central nervous system, neurodegenerative diseases

Trademark Events

Jan 31, 2024

Notice Of Approval Of Extension Request E-Mailed

Jan 29, 2024

Sou Extension 2 Granted

Jan 29, 2024

Sou Extension 2 Filed

Jan 29, 2024

Sou Teas Extension Received

Aug 19, 2023

Notice Of Approval Of Extension Request E-Mailed

Aug 17, 2023

Sou Extension 1 Granted

Aug 17, 2023

Sou Extension 1 Filed

Aug 17, 2023

Sou Teas Extension Received

Feb 21, 2023

Noa E-Mailed - Sou Required From Applicant

Dec 27, 2022

Official Gazette Publication Confirmation E-Mailed

Dec 27, 2022

Published For Opposition

Dec 7, 2022

Notification Of Notice Of Publication E-Mailed

Nov 22, 2022

Approved For Pub - Principal Register

Nov 18, 2022

Assigned To Examiner

Feb 11, 2022

New Application Office Supplied Data Entered

Feb 10, 2022

New Application Entered